
When to Stop Tirzepatide Before Surgery: What to Ask


There is no single stop date for everyone taking tirzepatide before surgery. Current multisociety guidance says most patients can continue GLP-1-based medicines before elective procedures, while some need extra precautions because of symptoms, recent dose changes, or other risks for delayed stomach emptying. Ask your anesthesiologist, procedural clinician, and prescriber to agree on your instructions. Follow the plan they give you rather than choosing a pause length yourself.
A blanket rule to stop for one week, several weeks, or a fixed number of drug half-lives does not capture current guidance. The central question is how to manage your procedure safely while accounting for the reason you take tirzepatide.
Why tirzepatide can affect anesthesia planning
Tirzepatide delays stomach emptying. During general anesthesia or deep sedation, retained stomach contents can enter the airway and lungs, a complication called aspiration. The Zepbound label reports rare aspiration events in patients receiving GLP-1 medicines despite reported adherence to fasting instructions.
This concern can apply to procedures such as endoscopy as well as operations. Tell the team about the medicine even when the appointment is described as a quick outpatient procedure.
The current label also says that available information is insufficient to establish whether withholding the medicine or changing fasting instructions reduces retained stomach contents. That uncertainty is one reason a universal medication calendar is inappropriate.
The American Society of Anesthesiologists provides a patient guide to diabetes and weight-loss medicines before surgery that explains the need for an individualized discussion.
Does tirzepatide's half-life tell you when to stop?
The current Zepbound prescribing information reports an elimination half-life of approximately five to six days. Half-life describes how quickly drug levels decline; it is not a measurement showing that the stomach is empty or that anesthesia is safe.
The Zepbound prescribing information therefore should not be turned into a personal stop-and-restart calculator. Your team must also consider symptoms, treatment stage, the procedure, and the potential effects of interrupting treatment.
For someone taking tirzepatide for diabetes, withholding it can raise blood glucose. Any interruption may require coordinated instructions for monitoring and other diabetes medicines. These decisions belong with the clinicians responsible for your care.
Who may need a medication pause or extra precautions?
The multisociety guidance highlights several circumstances that can increase concern about delayed stomach emptying: a period of dose escalation, significant gastrointestinal symptoms, higher doses associated with more symptoms, and other conditions that slow stomach emptying.
Tell the team about nausea, vomiting, abdominal pain, constipation, or unusual fullness. Explain whether you can eat and drink normally and whether symptoms began after a dose change. A symptom history is useful information; it does not prove that your stomach is either full or empty.
If you are unsure how to describe the pattern, the clinic's GLP-1 side-effects timeline can help you organize notes for the preoperative appointment. New or worsening symptoms still need direct assessment.
Depending on the assessment, the team may recommend a temporary diet modification, adjust the anesthesia approach, use gastric ultrasound when available, or delay an elective procedure. Continuing medication is appropriate for many patients, but it is not a promise that every procedure can proceed without changes.
What to ask before surgery or sedation

Raise the question early enough for the clinicians to communicate. Do not wait until you arrive for anesthesia to mention tirzepatide.
Provide the following information:
- The exact medication and prescribed dose, including the product packaging if helpful.
- The date of your most recent injection and when the next one is due.
- When treatment started and whether the dose recently changed.
- Current stomach or bowel symptoms and any difficulty eating or drinking.
- Diabetes medicines, supplements, other prescriptions, and relevant medical conditions.
Ask for written instructions that cover medication, food, fluids, glucose monitoring when relevant, and whom to call if symptoms change. Confirm which clinician will resolve any difference between the prescriber's advice and the facility's instructions.
If your team recommends a liquid diet
For selected higher-risk patients, the guidance describes a liquid-only diet for 24 hours before the procedure as one possible precaution. Use it only as directed by your procedural team, together with their specific fasting instructions.
Ask exactly which liquids are allowed and when each must stop. A protein shake, milk-containing drink, or smoothie should not be assumed to qualify as a clear liquid. The facility's instructions matter more than a general list of foods that usually feel comfortable on the medication.
Outside the prescribed fasting period, a guide to food choices during GLP-1-related nausea may help describe what you have been able to tolerate. It does not replace the procedure's preparation instructions.
Do not extend fasting on your own to compensate for taking a dose. If you took the medicine contrary to an agreed plan, ate or drank outside the instructions, or developed symptoms, contact the procedural team promptly and report exactly what happened.
When can you restart tirzepatide after surgery?
Confirm your last dose, recent intake, and current symptoms with the anesthesia team. They may reassess the plan using the information available that day. If an elective procedure needs to be delayed, ask what must change before it can be rescheduled.
Before discharge, clarify whether any medication pause continues and who will advise you about resuming treatment. The plan should account for recovery, food and fluid tolerance, glucose management when relevant, and the length of any interruption. Do not automatically restart a previous dose after a prolonged break.
For emergency surgery, do not delay seeking care to allow a medication washout. Tell the emergency and anesthesia teams that you use tirzepatide and when you last took it. They can use appropriate precautions.
Coordinating with Maryland Trim Clinic
For patients receiving care in Laurel, MD, Maryland Trim Clinic's medical weight-loss program includes medical evaluation and follow-up. Bring the procedure date and the surgical team's instructions to your prescribing clinician so medication questions can be coordinated. The procedural and anesthesia teams determine the preparation and anesthesia plan.
Frequently Asked Questions
Is stopping tirzepatide for seven days enough?
There is no universal seven-day rule that answers every patient's situation. Current guidance supports continuation for many patients and individualized precautions for others. Ask the team responsible for your procedure which plan applies.
What if my facility tells me to hold a dose?
Do not disregard the instructions or substitute an online schedule. Ask the anesthesia team and prescriber to confirm the reason, the exact plan, and any monitoring or restart instructions.
Does this apply to colonoscopy or endoscopy?
Yes, medication history can matter when a procedure involves deep sedation or general anesthesia. Tell the procedural team and follow its medication, bowel-preparation, diet, and fasting instructions.
Can I restart tirzepatide as soon as I get home?
Do not assume so. Confirm your next dose with the prescribing and procedural teams, especially after a longer interruption or when recovery affects eating and drinking. Your discharge instructions should identify whom to contact.
Need help planning around surgery?
Talk with the Maryland Trim Clinic team about your tirzepatide questions before your procedure. Bring your surgery date and current instructions so your care can be coordinated.